Skip to content
SmartFigure
UTI Mutual Fund

UTI CRISIL SDL Maturity April 2033 Index Fund

UTI Mutual Fund · Direct plan · Growth

  • Index & ETF
  • Index Fund
  • Moderate Risk
  • Rank 157 of 167 over 3 years
3-year returns
7.1%
a year
NAV
₹13.02
▼ 0.22% · 13 Nov 2026
Fund size
₹266 Cr
Expense ratio
0.17%
a year
Minimum SIP
₹500

Figures are for the Direct plan. The Regular plan, bought through a distributor, is at ₹12.89 and has returned 6.82% a year over 3 years.

Returns, and where it stands

Against the average index fund, and its place among them. Anything longer than a year is a yearly rate.

PeriodThis fundCategoryRank
1 year3.3%2.3%ahead151 of 318
3 years7.1%10.5%behind157 of 167
Every period, and the Regular plan →
PeriodDirectRegular
1 month0.8%0.8%
3 months-1.2%-1.3%
6 months2.6%2.5%
1 year3.3%3%
2 yearsp.a.5.2%4.9%
3 yearsp.a.7.1%6.8%

Figures are for the Direct plan, and the rank compares it against the same plan of its peers, best first. Based on NAV history from Dec 2022.

Plan

NAV history

▲ 3.26% in the last 1Y

12.512.913.213 Nov 202518 May 202613 Nov 2026

Hover or tap the chart for the NAV on any date. Past NAVs are adjusted for unit splits.

If you had invested in this fund

Investment type
₹
years
Total invested
₹1,80,000
Gain
₹14,968
XIRR (per year)
5.27%
Value today
₹1,94,968

36 monthly instalments from 17 Nov 2023, valued at the latest NAV. Past returns do not guarantee future returns.

What the ride has been like

Worked out from this fund's own NAV history, not a rating.

How bumpy
2.4% a year
10.1% less than the category average — the steadier side
Worst fall so far
−2.6%
Aug 2026 to Oct 2026.
Years that made money
100%
Of every one-year stretch it has been through.
Over any three years
6.5% to 8.3%
A year, at worst and at best. Typically 7.4%.

Fund details

Minimum lumpsum
₹5,000
Minimum top-up
₹5,000
Lock-in
None
Plan started
22 Dec 2022
Expense ratio
0.17%
as of 30 Sept 2026

Managed by Jaydeep Bhowal

Direct plan figures, last checked on 7 Nov 2026. Exit load and the scheme's benchmark are in thescheme document.

How it compares

UTI CRISIL SDL Maturity April 2033 Index Fund against other funds in the Index Fund category
Fund1Y3Y5YExpenseFund size
ICICI Prudential NASDAQ 100 Index Fund17.11%27%17.05%0.63%₹3,738 Cr
Motilal Oswal S&P 500 Index Fund17.88%24.99%16.03%0.49%₹2,919 Cr
ICICI Prudential Nifty Pharma Index Fund25.92%22.66%–0.51%₹163 Cr
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund22.77%21.88%15.76%0.55%₹192 Cr
ICICI Prudential Nifty Auto Index Fund2.73%19.99%–0.35%₹234 Cr
Motilal Oswal BSE Enhanced Value Index Fund-1.19%18.86%–0.52%₹2,132 Cr
UTI CRISIL SDL Maturity April 2033 Index Fund3.26%7.09%–0.17%₹266 Cr

About UTI CRISIL SDL Maturity April 2033 Index Fund

UTI CRISIL SDL Maturity April 2033 Index Fund is a index fund managed by UTI Mutual Fund. Passively track a market index such as the Nifty 50 or Sensex, with low costs and returns close to the index.

The investment objective of the scheme is to track the Index by investing in securities as represented by CRISIL IBX SDL Index – April 2033, subject to tracking errors. However, there is no guarantee or assurance that the investment objective of the scheme will be achieved.

The scheme's stated objective, as published by UTI Mutual Fund.

The NAV (net asset value) is the price of one unit of the fund. It is published by the fund house every business day and changes with the value of the fund's holdings. The Growth option reinvests all gains, so its NAV reflects the fund's total return.

Tax on your gains

Gains are taxed as equity: sell within 12 months and the gain is short-term, taxed at 20%. Hold longer and it is long-term, taxed at 12.5% on gains above ₹1.25 lakh in a financial year, across all your equity investments.

Work out what you would owe with the capital gains tax calculator.

Every plan and option, with scheme codes
PlanOptionNAVScheme code
DirectGrowth₹13.0173151185
RegularGrowth₹12.8901151184

Frequently asked questions

What is the NAV of UTI CRISIL SDL Maturity April 2033 Index Fund today?

The NAV of UTI CRISIL SDL Maturity April 2033 Index Fund (Direct plan, Growth) is ₹13.0173 and the Regular plan NAV is ₹12.8901, as of 13 Nov 2026.

What returns has UTI CRISIL SDL Maturity April 2033 Index Fund given?

Over the last year the Direct plan returned 3.26%, and 7.09% a year over 3 years. That places it 157 of 167 funds in its category over 3 years. Past returns do not guarantee future returns.

What is the expense ratio of UTI CRISIL SDL Maturity April 2033 Index Fund?

The Direct plan charges 0.17% a year, as disclosed on 30 Sept 2026. The fee is already taken out of the NAV, so the returns above are what you keep.

What is the minimum SIP amount in UTI CRISIL SDL Maturity April 2033 Index Fund?

You can start a monthly SIP with ₹500, or invest a lump sum of ₹5,000 or more.

How much has UTI CRISIL SDL Maturity April 2033 Index Fund fallen in the past?

Its deepest fall was 2.6% from 13 Aug 2026 to 28 Oct 2026. Of every one-year stretch in its history, 100% ended in a gain.

Which category does UTI CRISIL SDL Maturity April 2033 Index Fund belong to?

It is a Index Fund from UTI Mutual Fund. Passively track a market index such as the Nifty 50 or Sensex, with low costs and returns close to the index.

What is the difference between the Direct and Regular plan?

Both invest in the same portfolio. The Direct plan is bought straight from the fund house or a direct platform and has a lower expense ratio because no distributor commission is paid, so its NAV grows slightly faster over time.

How are gains from UTI CRISIL SDL Maturity April 2033 Index Fund taxed?

Gains are taxed as equity: sell within 12 months and the gain is short-term, taxed at 20%. Hold longer and it is long-term, taxed at 12.5% on gains above ₹1.25 lakh in a financial year, across all your equity investments.

Source: NAVs published by the fund house through AMFI. Mutual fund investments are subject to market risks; read all scheme-related documents carefully. Past performance does not guarantee future returns. This page is for information only and is not a recommendation to buy or sell.